| MSD Merck Sharp & Dohme AG - Varivax, Pulver und Lösungsmittel zur Herstellung einer Injektionssuspension |
| 00688 | | 01 | | Varivax | | Pulver und Lösungsmittel zur Herstellung einer Injektionssuspension | | J07BK01 | | Varicella, Live Attenuated | | 18.02.2005 | | |
|
| Composition |
| Praeparatio cryodesiccata: virus varicellae vivus (Stamm: OKA) min. 1350 U., saccharum, gelatina hydrolysata, ureum, natrii chloridum, natrii hydrogenoglutamas, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, kalii chloridum pro praeparatione corresp. natrium 0.96 mg et kalium 0.04 mg.
Solvens: aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | | Injection suspension | | | | | | | | Active Agent | Dose |
|---|
| Virus Varicellae Vivus (Stamm Oka) | 1350 U |
| | BAG: Active Agent | Dose |
|---|
| Virus Varicellae Vivus (Stamm Oka) | 1350 U |
| | | | Inactive agents |
|---|
| Disodium Phosphate Dihydrate | | Gelatina Hydrolysata | | Potassium Chloride | | Potassium Dihydrogenophosphate | | Sodium Chloride | | Natrii Hydrogenoglutamas | | Saccharum | | Ureum |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | Durchstechflasche(n) | 39.26 | 59.10 | B | SL | No |
|
